Skip to main content

Published locations for Monoclonal antibody slowed cognitive decline, cleared Alzheimer’s plaques in phase 2 trial

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Monoclonal antibody slowed cognitive decline, cleared Alzheimer’s plaques in phase 2 trial

User login

  • Reset your password
  • /content/monoclonal-antibody-slowed-cognitive-decline-cleared-alzheimers-plaques-phase-2-trial
  • /familypracticenews/article/171171/alzheimers-cognition/monoclonal-antibody-slowed-cognitive-decline
  • /internalmedicinenews/article/171171/alzheimers-cognition/monoclonal-antibody-slowed-cognitive
  • /psychiatry/article/171171/alzheimers-cognition/monoclonal-antibody-slowed-cognitive-decline-cleared
  • /internalmedicine/article/171171/alzheimers-cognition/monoclonal-antibody-slowed-cognitive-decline
  • /neurology/article/171171/alzheimers-cognition/monoclonal-antibody-slowed-cognitive-decline-cleared
  • /familymedicine/article/171171/alzheimers-cognition/monoclonal-antibody-slowed-cognitive-decline
  • /clinicalneurologynews/article/171171/alzheimers-cognition/monoclonal-antibody-slowed-cognitive
  • /clinicalpsychiatrynews/article/171171/alzheimers-cognition/monoclonal-antibody-slowed-cognitive